Hanoi-based children’s hospital capable of testing SARS-CoV-2
The Ministry of Health on March 7 decided to allow the Department of Biomolecular Research for Infectious Diseases under the Hanoi-based National Children’s Hospital to perform tests for the novel coronavirus SARS-CoV-2.
Hanoi (VNA) – The Ministry of Health on March 7decided to allow the Department of Biomolecular Research for InfectiousDiseases under the Hanoi-based National Children’s Hospital to perform tests forthe novel coronavirus SARS-CoV-2.
At present, laboratories across Vietnam capable of testingfor SARS-CoV-2 are based at the National Institute of Hygiene and Epidemiologyin Hanoi, the Pasteur Institute in Ho Chi Minh City, the Pasteur Institute ofNha Trang in Khanh Hoa province, the Institute of Hygiene and Epidemiology ofthe Central Highlands in Dak Lak province, and the National Institute ofMalariology-Parasitology-Entomology in Hanoi.
These facilities also include the National Hospital forTropical Diseases and Bach Mai Hospital; the Hospital for Tropical Diseases andCho Ray Hospital in HCM City; and Hue Central Hospital in Thua Thien-Hueprovince.
Disease control centres in Hanoi, Da Nang city and theprovinces of Quang Ninh, Thanh Hoa, Bac Ninh, Bac Giang, Ha Tinh and Lao Caiare also able to perform tests for SARS-CoV-2
The Ministry of Health on March 7 afternoon confirmed the 18th COVID-19infection case in Vietnam, who is a patient returning from the epidemic-hitRepublic of Korea (RoK).
A day earlier, the 17th infection case was reported in the capital cityof Hanoi. The 26-year-old female patient earlier visited her sister in the UK,then travelled to Italy and returned to Hanoi on March 1 on flight VN0054.
Vietnam has to date detected 18 COVID-19 infection cases. Of them, 16patients had been successfully cured and discharged from hospitals./.
The Ministry of Health on February 26 decided to allow the Hue Central Policlinic and the Ho Chi Minh City Hospital of Tropical Diseases to perform tests for SARS-CoV-2 that causes the ravaging acute respiratory disease (COVID-19).
A training course on preventing the spread of COVID-19 at medical facilities is taking place in Hanoi from February 27-28, bringing together nearly 150 attendees from hospitals nationwide.
The National Institute of Hygiene and Epidemiology reported a case testing positive to COVID-19 at 21:30 on March 6, the Health Ministry said late the same day.
The Ministry of Health on March 7 afternoon confirmed the 18th COVID-19 infection case in Vietnam, who is a patient returning from the epidemic-hit Republic of Korea (RoK).
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Testing for the SARS-CoV-2 (Photo: VNA) 
